Literature DB >> 7635599

Prevalence of senile dementia in Okinawa, Japan. COSEPO Group. Study Group of Epidemiology for Psychiatry in Okinawa.

C Ogura1, H Nakamoto, T Uema, K Yamamoto, T Yonemori, T Yoshimura.   

Abstract

METHODS. The prevalence of dementia was investigated in Okinawa Prefecture, Japan. In all, 3524 subjects, > or = 65 years old, were sampled randomly (urban and rural populations 61.1% and 38.9% respectively). Phase 1 of the survey was carried out by specially trained students of the Faculty of Medicine who used the Mini-Mental State (MMS) scale (interview rate: 94.3%) to screen 522 (15.8%) of the 3312 subjects for the phase 2 survey. Phase 2, conducted by psychiatrists using the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R) criteria, detected 172 cases of dementia. RESULTS. The estimated prevalence of dementia was 6.7%. For women, the rate increased sharply in the 90-99 year old group, and was 41.4%; for men in the 90-99 year old group prevalence was 21.2%. The ratio of Alzheimer-type dementia to multi-infarct dementia was 1.5:1 (men 1.2:1, women 1.7:1). The breakdown of the severity of dementia in the total cases was: mild 16.9%, moderate 30.8%, and severe 52.3%. The number of severe cases increased with age.

Entities:  

Mesh:

Year:  1995        PMID: 7635599     DOI: 10.1093/ije/24.2.373

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  10 in total

Review 1.  The burden of mental disorders.

Authors:  William W Eaton; Silvia S Martins; Gerald Nestadt; O Joseph Bienvenu; Diana Clarke; Pierre Alexandre
Journal:  Epidemiol Rev       Date:  2008-09-19       Impact factor: 6.222

2.  A cross-sectional population-based study on senile dementia in a rural city.

Authors:  M Honda; Y Kusaka; A Morita; S Nagasawa; K Umino; K Isaki
Journal:  Environ Health Prev Med       Date:  2000-04       Impact factor: 3.674

3.  Genetic determinants of exceptional human longevity: insights from the Okinawa Centenarian Study.

Authors:  D Craig Willcox; Bradley J Willcox; Wen-Chi Hsueh; Makoto Suzuki
Journal:  Age (Dordr)       Date:  2006-12-08

Review 4.  Healthy aging diets other than the Mediterranean: a focus on the Okinawan diet.

Authors:  Donald Craig Willcox; Giovanni Scapagnini; Bradley J Willcox
Journal:  Mech Ageing Dev       Date:  2014-01-21       Impact factor: 5.432

5.  Very old adults with better memory function have higher low-density lipoprotein cholesterol levels and lower triglyceride to high-density lipoprotein cholesterol ratios: KOCOA Project.

Authors:  Yuriko Katsumata; Hidemi Todoriki; Yasushi Higashiuesato; Shotoku Yasura; Yusuke Ohya; D Craig Willcox; Hiroko H Dodge
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  Cognitive Performance Among Older Persons in Japan and the United States.

Authors:  Yasuhiko Saito; Jung Ki Kim; Shieva Davarian; Aaron Hagedorn; Eileen M Crimmins
Journal:  J Am Geriatr Soc       Date:  2019-09-11       Impact factor: 5.562

7.  Prevalence of functional cognitive impairment and associated factors in Brazilian community-dwelling older adults.

Authors:  Andréa Silva Gondim; João Macedo Coelho Filho; Alexandre de Andrade Cavalcanti; Jarbas de Sá Roriz Filho; Charlys Barbosa Nogueira; Arnaldo Aires Peixoto Junior; José Wellington de Oliveira Lima
Journal:  Dement Neuropsychol       Date:  2017 Jan-Mar

8.  Systematic review of dementia prevalence 1994 to 2000.

Authors:  Marcos Antonio Lopes; Sérgio Ricardo Hototian; Geraldo C Reis; Hélio Elkis; Cassio Machado de Campos Bottino
Journal:  Dement Neuropsychol       Date:  2007 Jul-Sep

9.  Trends in the prevalence of dementia in Japan.

Authors:  Hiroko H Dodge; Teresa J Buracchio; Gwenith G Fisher; Yutaka Kiyohara; Kenichi Meguro; Yumihiro Tanizaki; Jeffrey A Kaye
Journal:  Int J Alzheimers Dis       Date:  2012-10-03

10.  A door-to-door survey to estimate the prevalence of Parkinsonism in Pakistan.

Authors:  Suliman Khan; Ghulam Nabi; Muhammad Naeem; Liaqat Ali; Peter A Silburn; George D Mellick
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-21       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.